Trident Lifeline Limited increased its stake in subsidiary Trident Mediquip Limited from 51% to 60.04% by acquiring an additional 9.04% equity for about Rs 4.42 crore in cash. The move, conducted on an arm’s length basis, strengthens Trident Lifeline’s control and presence in the pharmaceutical and healthcare segment.
Trident Lifeline Limited has strengthened its hold in subsidiary Trident Mediquip Limited by acquiring an additional 9.04% equity stake, taking its total shareholding to 60.04%. The acquisition, valued at around Rs 4.42 crore, was executed through a cash transaction on an arm’s length basis.
Trident Lifeline, a pharmaceutical company based in Gujarat, continues to consolidate its position within the healthcare segment through deeper ownership in its subsidiary.
Key Highlights
-
The company acquired 7,03,000 equity shares of Trident Mediquip Limited from existing shareholders, raising its stake from 51% to 60.04%.
-
The total investment is approximately Rs 4.42 crore, executed in cash consideration.
-
Trident Mediquip Limited, incorporated in October 2019 and based in Surat, operates within the pharmaceuticals and chemical industry.
-
The subsidiary reported a turnover of Rs 21.29 crore for FY 2024-25, with an authorized share capital of Rs 8 crore and a paid-up capital of Rs 7.78 crore.
-
The transaction qualifies as a related party transaction, as members of the promoter group — including Mr. Amit Bhupendra Halvawala, Mr. Chetan Chandrakant Jariwala, and Mr. Hardik Jigishkumar Desai — hold positions in both companies.
-
The move aligns with Trident Lifeline’s strategic aim to strengthen control over its operational subsidiaries within the pharma segment.
Sources: BSE Filing, Trident Lifeline Limited Corporate Announcements